The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In part 2 of the GPO or Local/Self Contracting webcast series, the panel considers the multiple product categories and the process of choosing the
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…
On-Demand Educational Webinars
In order to compare baseline costs to savings and determine areas of compliance risk, supply chain professionals need to work closely with their…
Podcasts
Now that the entire healthcare field is increasing its focus on value-based care, supply chain and physicians are working more closely together.
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
e-Learning
Become an expert in health care inventory management with AHRMM's certification program. Gain the skills to optimize your supply chain. Enroll now!